Cargando…
Overview of Chemotherapy for Gastric Cancer
Gastric cancer (GC) is one of the most clinically challenging cancers worldwide. Over the past few years, new molecular-targeted agents and immunotherapy have markedly improved GC prognosis. Human epidermal growth factor receptor 2 (HER2) expression is a key biomarker in first-line chemotherapy for...
Autores principales: | Sato, Yasushi, Okamoto, Koichi, Kida, Yoshifumi, Mitsui, Yasuhiro, Kawano, Yutaka, Sogabe, Masahiro, Miyamoto, Hiroshi, Takayama, Tetsuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959005/ https://www.ncbi.nlm.nih.gov/pubmed/36835872 http://dx.doi.org/10.3390/jcm12041336 |
Ejemplares similares
-
Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives
por: Sato, Yasushi, et al.
Publicado: (2023) -
Clinicopathological characteristics of early gastric cancer associated with autoimmune gastritis
por: Kitamura, Shinji, et al.
Publicado: (2021) -
“Tip-in underwater endoscopic mucosal resection” without submucosal injection for superficial nonampullary duodenal adenomas
por: Okamoto, Koichi, et al.
Publicado: (2023) -
Case Report: Longitudinal monitoring of clonal evolution by circulating tumor DNA for resistance to anti-EGFR antibody in a case of metastatic colorectal cancer
por: Sagawa, Tamotsu, et al.
Publicado: (2023) -
Treatment Response Predictors of Neoadjuvant Therapy for Locally Advanced Gastric Cancer: Current Status and Future Perspectives
por: Sato, Yasushi, et al.
Publicado: (2022)